NCT06582693 Refer2Quit: Evaluating a Proactive, Tailored, Population Health Approach for Tobacco Treatment for Household Smokers Through a Pediatric Care Network
| NCT ID | NCT06582693 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Children's Hospital of Philadelphia |
| Condition | Smoking |
| Study Type | INTERVENTIONAL |
| Enrollment | 3,200 participants |
| Start Date | 2024-09-06 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 3,200 participants in total. It began in 2024-09-06 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to compare the reach and effectiveness of the Refer2Quit intervention for increasing tobacco use treatment and quit rates among household members who smoke versus a treatment as usual group. This clinical trial also aims to study household member and pediatric patient characteristics that are associated with reach and effectiveness of Refer2Quit.
Eligibility Criteria
Adult Intervention Subject Inclusion Criteria * Males or females ages ≥18 years in age * Self-identify as a current combustible tobacco user * Have a valid cell phone number Child Intervention Subject Inclusion Criteria * Must be a CHOP patient Adult Intervention Subject Exclusion Criteria * \<18 years in age. * Indicates no combustible tobacco smoking Child Intervention Subject Exclusion Criteria * Not a CHOP patient Adult Control Subject Inclusion Criteria * Males or females ages ≥18 years in age * Self-identify as a current combustible tobacco user * Have a valid cell phone number Child Control Subject Inclusion Criteria * Must be a CHOP patient Adult Control Subject Exclusion Criteria * \<18 years in age. * Indicates no combustible tobacco smoking Child Control Subject Exclusion Criteria * Not a CHOP patient
Contact & Investigator
Brian P Jenssen, MD, MSHP
PRINCIPAL INVESTIGATOR
Children's Hospital of Philadelphia
Frequently Asked Questions
Who can join the NCT06582693 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Smoking. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06582693 currently recruiting?
Yes, NCT06582693 is actively recruiting participants. Contact the research team at jenssenb@chop.edu for enrollment information.
Where is the NCT06582693 trial being conducted?
This trial is being conducted at Philadelphia, United States.
Who is sponsoring the NCT06582693 clinical trial?
NCT06582693 is sponsored by Children's Hospital of Philadelphia. The principal investigator is Brian P Jenssen, MD, MSHP at Children's Hospital of Philadelphia. The trial plans to enroll 3,200 participants.